Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia

Lade...
Vorschaubild
Dateien
Amelio_2-qwc8z2qxaf9f3.pdf
Amelio_2-qwc8z2qxaf9f3.pdfGröße: 2.8 MBDownloads: 80
Datum
2021
Autor:innen
Mauriello, Alessandro
Scimeca, Manuel
Massoud, Renato
Novelli, Antonio
Di Lorenzo, Francesca
Finocchiaro, Susanna
Cimino, Carolina
Novelli, Giuseppe
Melino, Gerry
et al.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Cell death & disease. Nature Publishing Group. 2021, 12(8), 762. eISSN 2041-4889. Available under: doi: 10.1038/s41419-021-04058-z
Zusammenfassung

While vaccination is the single most effective intervention to drastically reduce severe disease and death following SARS-CoV-2 infection, as shown in UK and Israel, some serious concerns have been raised for an unusual adverse drug reaction (ADR), including vaccine-induced immune thrombotic thrombocytopenia (VITT) with concurrent low platelets as well as capillary leak syndrome. In fact, the overall safety of the vaccine is highlighted by the low frequency of ADR considering that in UK, by the early June, 40 million first doses and 29 million second doses have been injected; nonetheless, 390 thrombotic events, including 71 fatal events have been reported. Interestingly, the cases reported low platelet counts with the presence of anti-platelet factor-4 (PF4) antibodies, indicating an abnormal clotting reaction. Here, out of three referred cases, we report a post-vaccine clinical case of fatal thrombosis with postmortem examination and whole exome sequencing (WES) analysis, whose pathogenesis appeared associated to a preexisting condition of thrombocytopenia due to myelodysplasia.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690MAURIELLO, Alessandro, Manuel SCIMECA, Ivano AMELIO, Renato MASSOUD, Antonio NOVELLI, Francesca DI LORENZO, Susanna FINOCCHIARO, Carolina CIMINO, Giuseppe NOVELLI, Gerry MELINO, 2021. Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia. In: Cell death & disease. Nature Publishing Group. 2021, 12(8), 762. eISSN 2041-4889. Available under: doi: 10.1038/s41419-021-04058-z
BibTex
@article{Mauriello2021Throm-56539,
  year={2021},
  doi={10.1038/s41419-021-04058-z},
  title={Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia},
  number={8},
  volume={12},
  journal={Cell death & disease},
  author={Mauriello, Alessandro and Scimeca, Manuel and Amelio, Ivano and Massoud, Renato and Novelli, Antonio and Di Lorenzo, Francesca and Finocchiaro, Susanna and Cimino, Carolina and Novelli, Giuseppe and Melino, Gerry},
  note={Article Number: 762}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/56539">
    <dc:contributor>Novelli, Giuseppe</dc:contributor>
    <dc:creator>Di Lorenzo, Francesca</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56539/3/Amelio_2-qwc8z2qxaf9f3.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Cimino, Carolina</dc:contributor>
    <dc:creator>Mauriello, Alessandro</dc:creator>
    <dc:contributor>Amelio, Ivano</dc:contributor>
    <dc:creator>Finocchiaro, Susanna</dc:creator>
    <dc:contributor>Melino, Gerry</dc:contributor>
    <dcterms:issued>2021</dcterms:issued>
    <dc:creator>Amelio, Ivano</dc:creator>
    <dc:creator>Massoud, Renato</dc:creator>
    <dc:contributor>Di Lorenzo, Francesca</dc:contributor>
    <dcterms:abstract xml:lang="eng">While vaccination is the single most effective intervention to drastically reduce severe disease and death following SARS-CoV-2 infection, as shown in UK and Israel, some serious concerns have been raised for an unusual adverse drug reaction (ADR), including vaccine-induced immune thrombotic thrombocytopenia (VITT) with concurrent low platelets as well as capillary leak syndrome. In fact, the overall safety of the vaccine is highlighted by the low frequency of ADR considering that in UK, by the early June, 40 million first doses and 29 million second doses have been injected; nonetheless, 390 thrombotic events, including 71 fatal events have been reported. Interestingly, the cases reported low platelet counts with the presence of anti-platelet factor-4 (PF4) antibodies, indicating an abnormal clotting reaction. Here, out of three referred cases, we report a post-vaccine clinical case of fatal thrombosis with postmortem examination and whole exome sequencing (WES) analysis, whose pathogenesis appeared associated to a preexisting condition of thrombocytopenia due to myelodysplasia.</dcterms:abstract>
    <dc:creator>Novelli, Giuseppe</dc:creator>
    <dc:language>eng</dc:language>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:creator>Cimino, Carolina</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-14T11:00:06Z</dcterms:available>
    <dc:contributor>Finocchiaro, Susanna</dc:contributor>
    <dc:creator>Scimeca, Manuel</dc:creator>
    <dcterms:title>Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia</dcterms:title>
    <dc:contributor>Massoud, Renato</dc:contributor>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56539/3/Amelio_2-qwc8z2qxaf9f3.pdf"/>
    <dc:creator>Novelli, Antonio</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/56539"/>
    <dc:creator>Melino, Gerry</dc:creator>
    <dc:contributor>Mauriello, Alessandro</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-14T11:00:06Z</dc:date>
    <dc:contributor>Novelli, Antonio</dc:contributor>
    <dc:contributor>Scimeca, Manuel</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Ja
Diese Publikation teilen